While biopharmaceutical giant Amgen (AMGN) managed to eke out a modest gain on Friday, the past week has been rough, with AMGN stock losing 4%. Adding insult to injury, the equity is rated as a 72% Strong Sell by the Barchart Technical Opinion indicator. Despite the volatility risks, contrarians could be justified in betting on the healthcare juggernaut.Just like in America’s favorite pastime, the use of sabermetrics doesn’t guarantee that you’ll win baseball games. However, a consistent, empirical framewor ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and then buying some of the stock in the $40s.On Sept. 24, RBC Capital analyst Logan Reich reiterated Dutch Bros with an Outperform and maintained a price target of $85.American Bitcoin Corp (NASDAQ: ABTC) is a “total spec,” Cramer said.As per the recent news, American Bitcoin, on Thursday, named KPMG as new auditor.Recursion Pharmaceuticals (NASDAQ: RXRX) has been a “bad stock. We need to ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and then buying some of the stock in the $40s.On Sept. 24, RBC Capital analyst Logan Reich reiterated Dutch Bros with an Outperform and maintained a price target of $85.American Bitcoin Corp (NASDAQ: ABTC) is a “total spec,” Cramer said.As per the recent news, American Bitcoin, on Thursday, named KPMG as new auditor.Recursion Pharmaceuticals (NASDAQ: RXRX) has been a “bad stock. We need to ...

This company is challenging the leaders in its space.Coffee giant Starbucks (SBUX 0.86%) has been around for a long time, and its stock has created incredible shareholder value for longtime owners. It's been struggling for the past few years, but with new CEO Brian Niccol, the company is demonstrating improvement, and it pays an enticing dividend.However, if you're a growth investor, there's a new coffee chain that might whet your investing appetite instead. Consider Dutch Bros (BROS -5.91%), which has been ...

Key Takeaways Order-ahead hit 11.5% of transactions in Q2, with strong uptake in new markets.Throughput gains from dashboards and labor models lifted same-shop sales 6.1% in Q2.Dutch Bros added 31 shops in Q2, topping 1,040 units, with 2025 openings on track to exceed 160.Dutch Bros Inc. (BROS) is sharpening its focus on digital convenience and operational execution, with order-ahead and throughput initiatives becoming increasingly important traffic drivers.In the second quarter of 2025, order-ahead account ...

公司估值与市场表现 - 荷兰兄弟公司已成为热门品牌但估值处于高位[1] - 股价在季度报告发布后飙升但近期出现降温[1] 行业趋势与投资方法 - 观察宏观趋势和技术发展可获取人类社会进步的投资洞察[1] - 投资需关注基本面因素包括领导力质量和产品管线[1] - 中型企业和初创公司的营销与商业策略是重点研究领域[1] 分析师背景与研究范围 - 具备国际发展工作经验包括为外国总理办公室提供海外服务[1] - 专注于初创企业和新兴行业技术的评估工作[1] - 兼任科技与经济新闻记者的跨界经历[1]

Key Takeaways Dutch Bros Q2 revenues rose 28% y/y to $416M, with the adjusted EPS of $0.26 beating estimates. It opened 31 shops, expanding into Indiana and keeping the 2025 target of 160 openings on track. Loyalty program drove 72% of transactions, while mobile ordering grew to more than 11% of sales. Dutch Bros Inc. ((BROS) is demonstrating strong momentum as it seeks to capture a larger share of the growing U.S. coffee and beverage market.In second-quarter 2025, the company reported revenues of $416 mill ...

点击蓝字，关注我们 瑞银近日发布了其在消费板块的首选股票名单，并基于独家或特色数据来源，遴选出7只具 备差异化投资价值的个股。 瑞银近日发布了其在消费板块的首选股票名单，并基于独家或特色数据来源，遴选出7只具备差异 化投资价值的个股。以下是具体推荐： 百事可乐 "我们认为，未来12至18个月，百事可乐(PEP.US)将展现出显著的改善潜力， 是少数兼具防御属性 与估值扩张空间的大型必需消费品公司 。预计到2026年下半年，该公司有望恢复'符合算法预 期'的增长态势，同时2026年全年每股收益将实现高个位数的增长。综合来看，在所有推荐个股 中，百事可乐的风险收益比极具吸引力。" 斯马克 "我们的分析显示，得益于所属细分品类良好的增长态势，加之公司在咖啡业务板块具备的定价能 力 ， 斯 马 克 (SJM.US) 将 实 现 中 个 位 数 的 有 机 增 长 ， 这 一 增 长 足 以 抵 消 来 自 竞 争 对 手 Hostess(TWNKW.US)的持续压力。 我们预测其有机增长率将达到5.6%，高于市场普遍预期的 5.5%。 从利润端来看，成本节约成效、潜在的提价空间以及线下渠道优势，将为公司搭建一条实 现 ...

瑞银消费板块首选股票名单 - 基于独家或特色数据来源遴选出7只具备差异化投资价值的个股 [1] 百事可乐(PEPUS) - 未来12至18个月将展现出显著改善潜力 是少数兼具防御属性与估值扩张空间的大型必需消费品公司 [1] - 预计2026年下半年恢复符合算法预期的增长态势 2026年全年每股收益实现高个位数增长 [1] - 风险收益比极具吸引力 [1] 斯马克(SJMUS) - 得益于细分品类良好增长态势和咖啡业务定价能力 将实现中个位数有机增长 [1] - 有机增长率预计达56% 高于市场普遍预期的55% [1] - 成本节约成效 潜在提价空间和线下渠道优势将推动长期每股收益稳健增长 [1] 艾伯森(ACIUS) - 股价回调已过度 未反映潜在上涨空间 已摆脱与克罗格合并计划带来的干扰 [1] - 药房业务连续15个季度实现两位数增长 药房用户是终身客户价值最高的群体之一 [1] - 加大定价策略投入 有望推动食品杂货业务同店销售额增长 [1] Dutch Bros(BROSUS) - 门店扩张速度行业领先 销售额与客流量增长势头有望持续至2025年下半年及2026年 [2] - 在咖啡高增长品类中持续提升市场份额 预计实现20%以上营收增长 [2] - 增长依托消费者品牌认同感 新产品 营销活动 移动点单和运营效率提升 2026年将推出食品类产品 [2] Ulta Beauty(ULTAUS) - 新任首席执行官带领下展现强劲执行能力 内部运营效率显著提升 [2] - 2024年第二季度同店销售额增速加快 下半年面临温和同店销售对比基准 [2] - 2024财年销售 一般及管理费用投入增速放缓将推动盈利预期向上修正 [2] 昂跑(ONONUS) - 聚焦产品创新 运动性能提升 签约运动员与赛事合作 直营零售模式拓展 [3] - 坚守高端全价品牌定位 将实现行业领先销售额增长并突破利润率预期 [3] - 相较于多数服装家纺企业 在应对关税问题上具备更强优势 [3] Peloton(PTONUS) - 获得买入评级 目标价11美元 核心依据包括2026年预期EBITDA存在向上空间 [3] - 核心基础指标呈现积极向好趋势 风险收益比具备吸引力 [3] - 当前交易市盈率约6-7倍 EBITDA倍数 现金流处于拐点回升阶段 [3] - 订阅用户数量增长拐点是推动估值扩张的关键 需在季节性消费旺季实现订阅用户增长轨迹改善 [4]

I wrote about Dutch Bros Inc. (NYSE: BROS ) previously with a hold rating, as the valuation was already pricing in the upsides even though I like the fundamentals. The story has meaningfully improvedI am an individual investor that is now fully focus on managing my own capital that I have saved up over the years. My investing background spreads across a wide spectrum as I believe there are merits to each approach, for instance: Fundamental investing [Bottoms-up etc.], Technical investing [historical charts ...